Syndax Prescribed drugs has obtained FDA approval for a drug that addresses superior instances of acute leukemia and carries a particular genetic signature that results in an aggressive type of the illness. The regulatory resolution makes the Syndax drug the primary remedy in a brand new class of medication for blood cancers. The FDA approval particularly covers the therapy of […]